Institution statistics

Past rankings:

Ranking timeline:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

^*Ratio includes only projects with > 2 partners

Summary:

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Partners:

Constancy:

Subjects: Diversity index:0.19

Categories:

Project overview:

Start date	Project	acronym	role	funding	partners
2019-04-01	Single-cell genomics to comprehensively understand healthy B-cell maturation and transformation to chronic lymphocytic leukemia	BCLLatlas	participant	8.333.331	2
2019-01-01	HEalth data LInkage for ClinicAL benefit	HELICAL	participant	4.050.339	24
2019-01-01	EUCANCan: a federated network of aligned and interoperable infrastructures for the homogeneous analysis, management and sharing of genomic oncology data for Personalized Medicine.	EUCANCan	participant	5.999.453	18
2018-04-01	Human Brain Project Specific Grant Agreement 2	HBP SGA2	participant	88.000.000	130
2018-04-01	Graphene Flagship Core Project 2	GrapheneCore2	participant	88.000.000	145
2018-01-01	Testing the value of a novel strategic approach and its cost efficacy to improve the poor outcomes in Cardiogenic Shock	EURO SHOCK	participant	6.499.573	14
2018-01-01	Optimizing response to Li treatment through personalized evaluation of individuals with bipolar I disorder: the R-LiNK initiative	R-LiNK	participant	7.702.532	21
2018-01-01	Interactive Computing E-Infrastructure for the Human Brain Project	ICEI	participant	24.999.874	130
2017-09-01	Personalised In-Silico Cardiology	PIC	participant	4.000.569	10
2017-04-01	Decoding mitochondrial nutrient-sensing programs in POMC neurons as key determinants of metabolic health	MITOSENSING	participant	1.999.573	1
2017-01-01	SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS	LIVERHOPE	coordinator	5.998.800	16
2017-01-01	Multiple manifestations of genetic and non-genetic factors in Multiple Sclerosis disentangled with a multi-omics approach to accelerate personalised medicine	MultipleMS	participant	14.721.453	21
2017-01-01	Evaluating a Combination of Immune-based Therapies to Achieve a Functional Cure of HIV Infection	HIVACAR	coordinator	6.685.111	14
2017-01-01	New siRNA Nanotherapy for Inflammatory Bowel Diseases, targeting Janus kinase 3	NEW DEAL	participant	5.999.179	11
2017-01-01	HARMONIzation and integrative analysis of regional, national and international Cohorts on primary Sjögren’s Syndrome (pSS) towards improved stratification, treatment and health policy making	HarmonicSS	participant	9.998.750	36
2016-11-01	KONFIDO - Secure and Trusted Paradigm for Interoperable eHealth Services	KONFIDO	participant	4.992.078	15
2016-09-01	Neural circuit dynamics underlying expectation and their impact on the variability of perceptual choices	PRIORS	participant	2.000.000	1
2016-05-01	A new therapeutic platform based on nanotechnology to promote T- and B-regulatory networks	NANOBreg	coordinator	158.122	1
2016-04-01	Personalised Connected Care for Complex Chronic Patients	CONNECARE	participant	4.964.189	10
2016-04-01	Human Brain Project Specific Grant Agreement 1	HBP SGA1	participant	89.000.000	117
2016-04-01	Graphene-based disruptive technologies	GrapheneCore1	participant	89.000.000	159
2016-02-01	Laser and Ultrasound Co-Analyzer for thyroid nodules	LUCA	participant	3.628.846	8
2016-01-01	Development of a systems biomedicine approach for risk identification, prevention and treatment of type 2 diabetes	T2DSystems	participant	5.998.603	11
2016-01-01	European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates	EHVA	participant	22.188.522	40
2016-01-01	Investigating the impact of meditation training on mental health and wellbeing in the ageing population	MEDIT-AGEING	participant	6.134.756	10
2016-01-01	Mechanisms underlying hepatocellular carcinoma pathogenesis and impact of co-morbidities.	HEP-CAR	participant	5.698.310	10
2015-09-01	Regulation of red cell life-span, erythropoiesis, survival, senescence and clearance	RELEVANCE	participant	3.896.559	14
2015-09-01	Sustainable intEgrated care modeLs for multi-morbidity: delivery, FInancing and performancE	SELFIE	participant	5.472.447	8
2015-06-01	Analysis of tridimensional changes caused by type 2 Diabetes-Associated varianTs	3D-ADAPT	coordinator	158.122	1
2015-05-01	Characterizing Atrial fibrillation by Translating its Causes into Health Modifiers in the Elderly	CATCH ME	participant	4.944.773	9
2015-05-01	Clinical evaluation of carbons of controlled porosity as a new therapeutic for the treatment of liver cirrhosis and non-alcoholic fatty liver disease.	CARBALIVE	participant	5.913.080	14
2015-04-09	The neural circuit mechanisms of anti-NMDA receptor encephalitis: revealing the role of NMDA receptors in spatial memory in mice	ISOLM	coordinator	223.002	1
2015-01-01	Computational and functional annotation of genomic elements during development of the model vertebrate zebrafish	ZENCODE	participant	3.948.844	11
2015-01-01	Aortic Valve Replacement using Individualised Regenerative Allografts: Bridging the Therapeutic Gap	ARISE	participant	4.954.992	9
2014-03-01	Multidisciplinary Approaches to Translational Research In Conduct Syndromes	MATRICS	participant	4.500.000	19
2014-02-01	Extracellular Vesicles and exosomes from adult stem cells in the regeneration of organ injury	EVESTEMINJURY	participant	1.249.747	4
2014-02-01	Of DNA methylation and looping of distant regulatory elements in mantle cell lymphoma	DNAMETHYLOOPMCL	coordinator	166.336	1
2013-12-01	Therapeutic TriMix / mRNA based Vaccine in Chronic HIV-1 Infected Patients Receiving Antiretroviral Therapy	IHIVARNA	coordinator	5.984.720	8
2013-12-01	Diagnosis of skin cancer using optics	DIAGNOPTICS	participant	2.372.000	7
2013-11-01	Aggression subtyping for improved insight and treatment innovation in psychiatric disorders	AGGRESSOTYPE	participant	6.000.000	23
2013-10-01	Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope	EU-CERT-ICD	participant	5.999.562	19
2013-10-01	Contrast-enhanced uLtrasound for livEr-disease eValuation: development and validation of a novel E-Health-software for Risk-stratification	CLEVER	coordinator	1.362.743	3
2013-10-01	Combined Molecular Microscopy for Therapy and Personalized Medication in Rare Anaemias Treatments	COMMITMENT	participant	5.999.982	9
2013-09-01	Targeting the HIV-1 Nucleocapsid Protein to fight Antiretroviral Drug Resistance	THINPAD	participant	5.691.950	5
2013-08-12	Metabolic Impact of Dietary Protein Supplementation in Surgical Weight Loss	MIPS	coordinator	265.737	1
2013-04-01	Brain connectomics: modeling disconnection syndrome in Multiple Sclerosis	CONNECTMS	coordinator	173.371	1
2013-01-01	Human monoclonal antibody therapy to prevent hepatitis C virus reinfection of liver transplants: advancing lead monoclonal antibodies into clinical trial	HEPAMAB	participant	5.986.903	7
2013-01-01	Computations and Organization of Retes Through the Interaction of\nComputational, Optical and Neurophysiological Investigations of the Cerebral cortex	CORTICONIC	coordinator	2.399.000	5
2013-01-01	Does vascular endothelial growth factor gene therapy safely improve outcome in severe early-onset fetal growth restriction?	EVERREST	participant	5.998.984	10
2013-01-01	A novel drug discovery method based on systems biology: combination therapy and biomarkers for Multiple Sclerosis	COMBIMS	participant	2.509.680	8

overview shows latest 50 from 87 projects (2000-01-01 - 2019-12-31)
A full list of projects can be found here: